Business & regional news

Month Year

Month Year

Your search returned 113 results

Nov 20, 2023

Medtronic receives CE Mark Approval for innovative technologies in pulsed field and cryoablation: PulseSelect™ Pulsed Field Ablation System and Nitron CryoConsole™ to advance treatment of atrial fibrillation

Simplicity, efficiency, efficacy with unmatched safety data to set a new standard in catheter ablation
- Cardiac Ablation Solutions
Nov 10, 2023

Medtronic announces 12-month study results showing DTM™ spinal cord stimulation programming provides long-term, significant pain relief for indicated chronic back pain patients not eligible for spine surgery

NOVA Study: On-label, prospective, multicenter, randomized controlled trial compared DTM™ SCS to conventional spinal cord stimulation
- Neuromodulation
Oct 12, 2023

Medtronic receives CE Mark for Evolut™ FX TAVI System for treatment of severe aortic stenosis

Next-Gen Evolut FX TAVI system enhances procedure ease-of-use, visualization, and predictability
- Structural Heart and Aortic
Oct 10, 2023

Medtronic receives FDA approval for SynchroMed™ III intrathecal drug delivery system for chronic pain, cancer pain, and severe spasticity
- Neuroscience
Aug 28, 2023

ESC Congress 2023: Real-world analyses highlight benefits of Medtronic ICDs for preventing sudden cardiac death

• Improved survival with ICD therapy: nearly 25% lower risk of death in indicated patients receiving an ICD vs. no ICD
• ICDs confer additional long-term benefits after initial device replacement
- Cardiac Rhythm Management

Show per page